Compass Point upgraded shares of Trulieve Cannabis (OTCMKTS:TCNNF) from a neutral rating to a buy rating in a research note published on Monday, Benzinga reports. Compass Point currently has $17.00 price objective on the stock, up from their prior price objective of $11.00.
TCNNF opened at $13.13 on Monday. The stock has a fifty day moving average price of $10.87 and a 200 day moving average price of $10.18. Trulieve Cannabis has a 1 year low of $6.68 and a 1 year high of $16.23.
Trulieve Cannabis Company Profile
Recommended Story: Backdoor Roth IRA
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.